Holen Sie sich die Stockscreener-App
21.71
4.34%
-1.09
Schlusskurs vom Vortag:
$22.80
Offen:
$22.58
24-Stunden-Volumen:
385.12K
Relative Volume:
1.21
Marktkapitalisierung:
$1.16B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-13.48
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
+4.25%
1M Leistung:
+52.30%
6M Leistung:
+112.57%
1J Leistung:
+36.31%
1-Tages-Spanne:
$21.66
$22.78
1-Wochen-Bereich:
$20.50
$23.23
52-Wochen-Spanne:
$6.42
$23.23
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
21.69 | 1.22B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-05-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Tyra Biosciences stock hits 52-week high at 22.83 USD By Investing.com - Investing.com Canada
June Brings on Some Huge Insider Buying - AOL.com
Tyra Biosciences (NASDAQ:TYRA) Raised to “Hold” at Wall Street Zen - Defense World
What makes Tyra Biosciences Inc. stock attractive to growth funds2025 Pullback Review & Stock Portfolio Risk Management - Newser
Aug Mood: Why Tyra Biosciences Inc. stock attracts high net worth investorsJuly 2025 Chart Watch & High Win Rate Trade Tips - BỘ NỘI VỤ
Can Tyra Biosciences Inc. stock resist market sell offsJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Goldman Sachs initiates coverage of Tyra Biosciences stock with Early-Stage Biotech rating - Investing.com UK
Sio Capital Management LLC Has $7.75 Million Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (TYRA) Stock Analysis Report | Financials & Insights - Benzinga
Should Tyra Biosciences’ (TYRA) Executive Hires Shift the Regulatory Outlook for Its Pipeline? - Sahm
Tyra Biosciences (NASDAQ:TYRA) Shares Gap DownHere's What Happened - MarketBeat
Tyra Biosciences appoints two key executives to leadership team By Investing.com - Investing.com Canada
Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - BioCentury
Tyra Biosciences appoints two key executives to leadership team - Investing.com
Tyra Biosciences Announces Executive Role Changes - TradingView
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer - Eastern Progress
Contrasting Milestone Pharmaceuticals (NASDAQ:MIST) and Tyra Biosciences (NASDAQ:TYRA) - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bull Bear: How Tyra Biosciences Inc. stock reacts to global recession fearsMarket Weekly Review & Weekly Chart Analysis and Guides - moha.gov.vn
Weekly Recap: Why Tyra Biosciences Inc. stock attracts high net worth investorsLong Setup & Fast Exit and Entry Strategy Plans - moha.gov.vn
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighWhat's Next? - MarketBeat
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Director Robert More Sells 246,871 Shares - MarketBeat
Tyra Biosciences (TYRA): Evaluating Valuation Following Phase 2 Milestone in Achondroplasia Pipeline - simplywall.st
Dir More Sells 246,871 ($5M) Of Tyra Biosciences Inc [TYRA] - TradingView
Check Out Tyra Biosciences Inc (TYRA)’s Trade Data Rather Than the Analysts’ Views - Setenews
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Non Muscle Invasive Bladder Cancer Pipeline Insights Report 2025: Emerging Therapies and Key Clinical Advances Reshaping the Future of Treatment - Barchart.com
Best Growth Stocks To Follow Today – November 22nd - Defense World
Insiders Who Sold US$628k Of Tyra Biosciences Made The Right Call - simplywall.st
Why Tyra Biosciences (TYRA) Is Up 34.3% After Launching Phase 2 Trial in Pediatric Achondroplasia - Sahm
Tyra Biosciences stock hits 52-week high at 21.19 USD By Investing.com - Investing.com Nigeria
What Makes Shree Ganesh Bio a Strong Contender in YEARHigh Frequency Trading Trends & Free Exceptional Risk Adjusted Gains - earlytimes.in
Tyra Biosciences stock hits 52-week high at 21.19 USD - Investing.com
There is no doubt that Tyra Biosciences Inc (TYRA) ticks all the boxes. - Setenews
Owner Alta Partners NextGen Fund II LP Files To Sell 256,871 Of Tyra Biosciences Inc [TYRA] - TradingView
Tyra Biosciences Insider Sold Shares Worth $2,030,923, According to a Recent SEC Filing - MarketScreener
Is Tyra Biosciences Inc. stock supported by strong fundamentalsJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Tyra Biosciences COO Bensen sells $2m in stock By Investing.com - Investing.com Canada
Insider Sell: Daniel Bensen Sells 125,589 Shares of Tyra Bioscie - GuruFocus
Risk vs reward if holding onto Tyra Biosciences Inc.Weekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should I hold or sell Tyra Biosciences Inc. stock in 2025Trade Volume Summary & Daily Stock Trend Watchlist - newser.com
Is Tyra Biosciences Inc. forming a reversal patternMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Has Tyra Biosciences Inc. found a price floorJobs Report & Momentum Based Trading Signals - newser.com
How to track smart money flows in Tyra Biosciences Inc.2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
Tyra Biosciences (NASDAQ:TYRA) Trading Up 8.4%Should You Buy? - MarketBeat
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):